Delivering DNA Aptamers Across the Blood–Brain Barrier Reveals Heterogeneous Decreased ATP in Different Brain Regions of Alzheimer’s Disease Mouse Models

Delivering DNA Aptamers Across the Blood–Brain Barrier Reveals Heterogeneous Decreased ATP in Different Brain Regions of Alzheimer’s Disease Mouse Models

Saved in:

Bibliographic Details
Main Authors:	Mandira Banik, Aaron P. Ledray, Yuting Wu, Yi Lu
Format:	Article
Language:	English
Published:	American Chemical Society 2024-07-01
Series:	ACS Central Science
Online Access:	https://doi.org/10.1021/acscentsci.4c00563
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Strategies for delivering drugs across the blood-brain barrier for the treatment of neurodegenerative diseases
by: Xiaopei Zhang, et al.
Published: (2025-08-01)

Intra-Arterially Delivered Mesenchymal Stem Cells Are Not Detected in the Brain Parenchyma in an Alzheimer's Disease Mouse Model.
by: Na Kyung Lee, et al.
Published: (2016-01-01)

Regional heterogeneity of the blood-brain barrier
by: Marie Blanchette, et al.
Published: (2025-08-01)

Assessing blood-brain barrier (BBB) integrity in an Alzheimer’s disease mouse model: is the BBB globally or locally disrupted?
by: Ehsan Nozohouri, et al.
Published: (2025-07-01)

Brain Ischemia in Alzheimer’s Disease May Partly Counteract the Disruption of the Blood–Brain Barrier
by: Grant A. Bateman, et al.
Published: (2025-03-01)

Correlations of blood and brain NMR metabolomics with Alzheimer’s disease mouse models
by: Franz Knörnschild, et al.
Published: (2025-03-01)

Photobiomodulation mitigates blood–brain barrier disruption in APP/PS1 mouse model of Alzheimer’s disease by activating the AMPK pathway
by: Chunyan Ma, et al.
Published: (2025-06-01)

Atp7b-dependent choroid plexus dysfunction causes transient copper deficit and metabolic changes in the developing mouse brain.
by: Clorissa L Washington-Hughes, et al.
Published: (2023-01-01)

Insights into the transcriptomic heterogeneity of brain endothelial cells in normal aging and Alzheimer’s disease
by: Qian Yue, et al.
Published: (2026-02-01)

Blood-brain barrier biomarkers modulate the associations of peripheral immunity with Alzheimer’s disease
by: Jia-Hui Hou, et al.
Published: (2025-04-01)

Blood–brain barrier disruption: a pervasive driver and mechanistic link between traumatic brain injury and Alzheimer's disease
by: Bryan Sun, et al.
Published: (2025-03-01)

Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer's disease.
by: Abdallah M Eteleeb, et al.
Published: (2024-04-01)

Facilitating DNAzyme transport across the blood-brain barrier with nanoliposome technology
by: Mohammad Javad Hoseinifar, et al.
Published: (2025-05-01)

Bioreactors for Decreasing the Growth of Brain Tumors
by: Rona S. Carroll, et al.
Published: (2001-01-01)

Breaking barriers: Aptamers in ocular disease treatment
by: Tao Wang, et al.
Published: (2024-12-01)

Detection of Intranasally Delivered Bone Marrow-Derived Mesenchymal Stromal Cells in the Lesioned Mouse Brain: A Cautionary Report
by: Elena H. Chartoff, et al.
Published: (2011-01-01)

Microspatial Heterogeneities and the Absence of Postmortem Contamination in Alzheimer’s Disease Brain Microbiota: An Alzheimer’s Pathobiome Initiative (AlzPI) Study
by: Myat N. Thwe, et al.
Published: (2025-04-01)

Enhancing aptamer selection in alzheimer’s disease: integrating structure prediction and molecular dynamics simulations
by: Benedikt Jakob Lohnes, et al.
Published: (2025-07-01)

Three-dimensional organotypic mouse brain slices to study Alzheimer’s disease pathologies: a review
by: Christian Humpel
Published: (2025-07-01)

Brain‐Wide Neuroregenerative Gene Therapy Improves Cognition in a Mouse Model of Alzheimer's Disease
by: Zheng Wu, et al.
Published: (2025-04-01)

Pitolisant alleviates brain network dysfunction and cognitive deficits in a mouse model of Alzheimer’s disease
by: Yang Zou, et al.
Published: (2025-04-01)

Physiological mouse brain Abeta levels are not related to the phosphorylation state of threonine-668 of Alzheimer's APP.
by: Yoshitake Sano, et al.
Published: (2006-12-01)

Maresin-like 1 Ameliorates Neuropathology of Alzheimer’s Disease in Brains of a Transgenic Mouse Model
by: Pallavi Shrivastava, et al.
Published: (2024-12-01)

Ultrasound blood–brain barrier opening: A new era of treatment for Alzheimer's disease?
by: Cuiping Wang, et al.
Published: (2024-12-01)

Penetration of linezolid and tedizolid in cerebrospinal fluid of mouse and impact of blood–brain barrier disruption
by: Marin Lahouati, et al.
Published: (2025-01-01)

Aging Reduces ATP-Binding Cassette Transporter Expression in Brain Microvessels of Mice
by: Yukiyo Wada, et al.
Published: (2025-01-01)

Gadolinium based contrast agent induced electrical conductivity heterogeneity analysis in the brain of Alzheimer’s disease
by: Geon-Ho Jahng, et al.
Published: (2025-03-01)

Extravasation of Borrelia burgdorferi Across the Blood–Brain Barrier is an Extremely Rare Event
by: Linus Wang, et al.
Published: (2025-05-01)

Towards Aptamer-Targeted Drug Delivery to Brain Tumors: The Synthesis of Ramified Conjugates of an EGFR-Specific Aptamer with MMAE on a Cathepsin B-Cleavable Linker
by: Vladimir A. Brylev, et al.
Published: (2024-11-01)

The blood-brain barrier
by: Robert D. Tschirgi
Published: (1958-12-01)

Withaferin A Rescues Brain Network Dysfunction and Cognitive Deficits in a Mouse Model of Alzheimer’s Disease
by: Linhan Yang, et al.
Published: (2025-05-01)

Hearing modulation affects Alzheimer’s disease progression linked to brain inflammation: a study in mouse models
by: Yoo-Seung Ko, et al.
Published: (2024-12-01)

Overcoming the Blood-Brain Barrier for Drug Delivery to the Brain
by: Jennifer S. Katz, et al.
Published: (2025-07-01)

18F-Fluorodeoxyglucose Uptake in Cerebrospinal Fluid Reflects Both Brain Glucose Demand and Impaired Blood–Brain Barrier Transport in Alzheimer’s Disease
by: Caterina Motta, et al.
Published: (2025-05-01)

Heterogeneity in pneumolysin expression governs the fate of Streptococcus pneumoniae during blood-brain barrier trafficking.
by: Manalee Vishnu Surve, et al.
Published: (2018-07-01)

Intranasal Administration as a Route to Deliver Drugs to the Brain (Review)
by: N. N. Porfiryeva, et al.
Published: (2021-11-01)

Recent advances of engineering cell membranes for nanomedicine delivery across the blood–brain barrier
by: Shengnan Yuan, et al.
Published: (2025-07-01)

Construction of Nicotinamide Mononucleotide-Loaded Liposomes and Their In Vitro Transport Across the Blood–Brain Barrier
by: Tiantian Wang, et al.
Published: (2024-12-01)

PepH3-modified nanocarriers for delivery of therapeutics across the blood-brain barrier
by: Anikó Szecskó, et al.
Published: (2025-04-01)

Chitosan alleviates symptoms of Parkinson’s disease by reducing acetate levels, which decreases inflammation and promotes repair of the intestinal barrier and blood–brain barrier
by: Yinying Wang, et al.
Published: (2026-01-01)